pooled estimates of diagnostic accuracy were computed using a random-effects model and Meta-DiSc Version 1.4. This meta-analysis is registered with PROSPERO (CRD42018074856).
Opiate Use for Headaches in Five Emergency Departments
LeFevere R, Salzman J, Moses L, Isenberger K/Healthpartners, St. Paul, MN Study Objectives: It is generally accepted that opiates should not be used for patients with primary headaches in the emergency department (ED), especially as firstline agents. Monitoring the use of opiates in such circumstances has become a common quality measure for physicians and EDs. Our primary objective was to describe opiate use for headaches in 5 different EDs, and also to examine whether there was significant variation between sites.
Methods: As part of a quality improvement project in 2017, each emergency physician in a 5-hospital system was asked to review 10 charts of 1 colleague. Patients who had a discharge diagnosis of headache over the previous year were grouped by treating physician and included in the analysis. Each physician's charts were then randomly assigned to a colleague who was instructed to review 10 charts. For each chart, the reviewing physician determined if an opiate was used to treat the patient's headache. If an opiate was given, it was noted whether it was the first medication given, or whether a nonopiate medication was given first. There were 5 hospitals included in the analysis. The majority of visits were at an urban adult and pediatric level-1 trauma center with an emergency medicine residency program. The other 4 sites were rural and suburban community hospitals with annual visit volumes between 8,000 and 14,000. The percentages of patients receiving opiates at the 5 sites were compared using a Fisher exact 3x2 contingency table.
Results: A total of 583 charts were reviewed by 52 physicians and included in the analysis (Table 1) . Opiates were used in 54/583 (9%) patients overall, and were the first medication given in 29/583 (5%) patients. There were small variations in the rate of opiate use between the sites, but none of the variation between any of the sites was statistically significant (p¼0.56).
Conclusions: Overall, use of opiates for headache in these 5 EDs was low, and there was no significant difference between the 5 sites. This could serve as a baseline rate of opiate use for headaches for future monitoring and studies. These results also suggest clinicians from varied ED settings are already minimizing opiate use for ED patients with headaches. Study Objectives: Many SCD patients do not have access to coordinated care and rely on emergency epartment (ED) visits to manage their pain. Inconsistent pain treatment leads to longer hospitalizations and patient distress. Patients with SCD often cite the care that is delivered in the ED as the area of health care in greatest need of improvement. In 2014, the National Heart, Lung, and Blood Institute released guidelines for the care of SCD, including recommendations for the management of acute sickle cell pain in the ED. The guidelines suggest that patients with SCD should be assessed and triaged rapidly, assigned high priority for evaluation by a physician, and receive their first analgesic within 60 minutes of arrival to the ED (or 30 min from 
